DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2023 Conference Call.

Related Keywords

United States ,Canada ,Australia ,Canadian ,Australian ,Scott Kellen ,Dietrich Pauls ,Rick Pauls ,Thomas Flaten ,Alex Nowak ,Scott Kasner ,Nasdaq ,Marinus Pharmaceuticals ,Nektar Therapeutics ,Health Canada ,Cubist Pharmaceuticals ,Australian Stroke Trials Network ,International Stroke Conference ,Diamedica Therapeutics Inc ,National Institutes Of Health Stroke Scale ,Opiant Pharmaceuticals ,Canadian Stroke Consortium ,Diamedica Therapeutics ,Call Transcript March ,Medica Therapeutics ,Diamedica Therapeutics Full Year ,Investor Relations ,Cautionary Statement Note ,Risk Factors ,Chief Executive ,Lorianne Masuoka ,Chief Medical Officer ,Chief Medical ,Epygenix Therapeutics ,Global Principal Investigator ,National Institutes ,Health Stroke Scale ,Rebekah De Vitry Fries ,Vice President ,Clinical Operations ,Lake Street ,Lowest Fertility ,